Celldex (CLDX +4%), Seattle Genetics (SGEN +3.2%), Ariad (ARIA +10.3%), and Pharmacylics (PCYC +6.3%) are a few more names that spiked on a report Roche is working on a bid for Alexion. On the other hand, Illumina (ILMN -1.4%) dipped lower.